Publications

Posters & Oral Communications

Updated list of our posters and oral communications…

0.-
9

  • Implantable device for intrathecal pseudodelivery of immunotherapies: preclinical testing of a prototype for humans

  • Pérez-Martín E, Rodríguez Cañón M, Álvarez G, Prado C, Tomás-Zapico C, Menéndez-González M.

  • 7th Clinical Trials on Alzheimer’s disease (CTAD), Madrid, Oct-Nov 2024

  • JPAD (The Journal of Prevention of Alzheimer’s Disease) (pending), 2024

8

  • Implantable device for intrathecal pseudodelivery of drugs: surgical protocol and proof-of-concept in a porcine model

  • Pérez-Martín E, Rodríguez-Cañón M, Roces-Llorián C, Álvarez G, Prado C, Tomás-Zapico C, Menéndez-González M.

  • SEIQ (Sociedad Española de Investigadores Quirúrgicos), Cáceres (Spain), Sep 2024

  • British Journal of Surgery (pending), 2024

7

  • Mejora de los procedimientos quirúrgicos y del bienestar animal para estrategias terapéuticas basadas en implantaciones intratecales a largo plazo en un modelo murino de enfermedad de Alzheimer

  • Pérez-Martín E, Álvarez Menéndez G, Prado C, Rodríguez-Cañón M, Coto-Vilcapoma A, Castilla-Silgado J, Pinto-Hernández P, Menéndez-González M, Tomás-Zapico C.

  • I Simposio Iberoamericano Virtual de Neurociencias: de la molécula a la conducta, Oviedo, Oct 2023

6
5
4

  • A new route of drug delivery for neurodegenerative dementias using a fully implantable device: proof of concept in mice

  • Menéndez-González M, Coto-Vilcapoma A, Castilla-Silgado J, Álvarez Vega M, Antuña Ramos A, Fernández-García B, Prado C, Álvarez G, Rodríguez M, Pérez E, Tomás-Zapico C.

  • Alzheimer Disease International, London & virtual, Jun 2022

3

  • A new route of drug delivery for neurodegenerative diseases using a fully implantable device: proof of concept in mice

  • Menéndez-González M, Coto-Vilcapoma A, Castilla-Silgado J, Fernández-García B, Álvarez Vega M, Antuña A, Tomás-Zapico C.

  • AD/PD 2022, Barcelona & virtual, Mar 2022

2

  • Intrathecal inverse release of drugs: an alternative route of delivery for antiamyloid compounds

  • Menéndez-González M, Castilla-Silgado J, Coto-Vilcapoma A, Álvarez-Vega M, Fernández-García B, Tomas-Zapico C.

  • 4th Clinical Trials on Alzheimer’s Disease (CTAD), Nov 2021

1